Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-13

Clinical Trial Update: Female Sexual Dysfunction, Risks and Outcomes (FSFI)

View source ↗

Summary

The clinical trial evaluating female sexual dysfunction (FSFI) has been withdrawn, with St. Louis University listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Louis University | Conditions: Female Sexual Dysfunction | Status: WITHDRAWN